Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Jun-16 3:12 PM View:  | Grupo Ferrer Internacional,... 10% Owner | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Purchase | 19,465,700 | $0.90 | $17,519,100.00 | 822% 2.37M to 21.83M | |
| 21-Jun-16 3:56 PM View: | Kamemoto Edwin S EVP, R&D, Regulatory & Quality | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 9,112 | -- | -- | (100%) 9.11K to 0 | |
| 21-Jun-16 3:42 PM View: | Pakianathan Deepika Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 658 | -- | -- | (< 1%) 99.63K to 98.97K | |
| 21-Jun-16 3:54 PM View: | King Thomas Braxton President & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 37,224 | -- | -- | (48%) 77.22K to 40.0K | |
| 21-Jun-16 3:42 PM View: | Pakianathan Deepika Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 98,967 | -- | -- | (100%) 98.97K to 0 | |
| 21-Jun-16 3:47 PM View: | Ringold Gordon Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 32,392 | -- | -- | (95%) 34.25K to 1.85K | |
| 21-Jun-16 3:52 PM View: | Turner Joseph L Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 1,050 | -- | -- | (100%) 1.05K to 0 | |
| 21-Jun-16 3:50 PM View: | Stein Issac Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 15,838 | -- | -- | (100%) 15.84K to 0 | |
| 21-Jun-16 3:54 PM View: | King Thomas Braxton President & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 40,000 | -- | -- | (100%) 40.0K to 0 | |
| 21-Jun-16 3:45 PM View: | Read J Leighton Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 3,492 | -- | -- | (100%) 3.49K to 0 | |
| 21-Jun-16 3:47 PM View: | Ringold Gordon Director | Alexza Pharmaceuticals Inc. (ALXA) | 21-Jun-16 | Disposition (change in control) | 1,854 | -- | -- | (100%) 1.85K to 0 | |
| 28-Sep-15 5:10 PM View: | Grupo Ferrer Internacional,... 10% Owner | Alexza Pharmaceuticals Inc. (ALXA) | 28-Sep-15 | Purchase | 125,000 | -- | -- | 6% 2.24M to 2.37M | |
| 09-Sep-13 4:56 PM View: | Ringold Gordon Director | Alexza Pharmaceuticals Inc. (ALXA) | 06-Sep-13 | Market Purchase | 10,000 | $4.77 | $47,700.00 | 41% 24.25K to 34.25K | (80%) |
| 26-Jul-13 4:34 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 26-Jul-13 | Market Purchase | 2,420 | $4.49 | $10,865.80 | < 1% 243.4K to 245.82K | (79%) |
| 26-Jul-13 4:34 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 25-Jul-13 | Market Purchase | 12,580 | $4.50 | $56,584.80 | 5% 230.82K to 243.4K | (79%) |
| 26-Jul-13 4:34 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 24-Jul-13 | Market Purchase | 25,000 | $4.48 | $111,900.00 | 12% 205.82K to 230.82K | (79%) |
| 02-Apr-13 5:26 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 175,000 | $4.42 | $773,500.00 | 580% 30.15K to 205.15K | (78%) |
| 02-Apr-13 5:39 PM View: | Schineller Peter W. SVP and CCO | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 100% 0 to 43.75K | (78%) |
| 02-Apr-13 5:18 PM View: | Moreland Darl SVP, Quality | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 1233% 3.55K to 47.3K | (78%) |
| 02-Apr-13 5:28 PM View: | Cassella James V EVP, R&D and CSO | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 233% 18.75K to 62.49K | (78%) |
| 02-Apr-13 5:32 PM View: | Oki Mark K SVP, CFO and Sec | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 756% 5.79K to 49.54K | (78%) |
| 02-Apr-13 5:36 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 1030% 4.25K to 48.0K | (78%) |
| 27-Feb-13 6:16 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 25-Feb-13 | Gift | 9,113 | -- | -- | (23%) 39.26K to 30.15K | |
| 27-Feb-13 6:16 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 25-Feb-13 | Gift | 9,113 | -- | -- | 30% 30.15K to 39.26K | |
| 08-Feb-13 4:33 PM View: | Cassella James V EVP, R&D and CSO | Alexza Pharmaceuticals Inc. (ALXA) | 07-Feb-13 | Grant | 17,795 | -- | -- | 1873% 0.95K to 18.75K | |
| 22-Jan-13 12:20 PM View: | Lansdowne Partners Austria ... 10% Owner | Alexza Pharmaceuticals Inc. (ALXA) | 18-Jan-13 | Market Sale | 25,000 | $4.75 | $118,750.00 | (< 1%) 3.09M to 3.07M | 80% |
| 22-Jan-13 12:20 PM View: | Lansdowne Partners Austria ... 10% Owner | Alexza Pharmaceuticals Inc. (ALXA) | 17-Jan-13 | Market Sale | 100,000 | $4.75 | $475,000.00 | (3%) 3.19M to 3.09M | 80% |
| 31-Dec-12 1:56 PM View: | Lansdowne Partners Austria ... 10% Owner | Alexza Pharmaceuticals Inc. (ALXA) | 27-Dec-12 | Market Purchase | 72,189 | $4.85 | $350,267.00 | 5% 1.57M to 1.65M | (80%) |
| 27-Dec-12 4:19 PM View: | Cassella James V EVP, R&D and CSO | Alexza Pharmaceuticals Inc. (ALXA) | 26-Dec-12 | Market Sale (Planned) | 4,558 | $4.90 | $22,315.50 | (83%) 5.51K to 0.95K | 81% |
| 27-Dec-12 4:27 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 26-Dec-12 | Market Sale (Planned) | 4,558 | $4.90 | $22,315.50 | (52%) 8.74K to 4.18K | 81% |
| 02-Apr-13 5:36 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 05-Dec-12 | txn.W.title | 68 | -- | -- | 2% 4.18K to 4.25K | |
| 29-Aug-12 5:35 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (25%) 40.71K to 30.71K | 77% |
| 29-Aug-12 5:27 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (56%) 17.96K to 7.96K | 77% |
| 29-Aug-12 5:30 PM View: | Moreland Darl SVP, Quality | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (84%) 11.91K to 1.91K | 77% |
| 29-Aug-12 5:39 PM View: | Cassella James V EVP, R&D and CSO | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (64%) 15.51K to 5.51K | 77% |
| 29-Aug-12 5:25 PM View: | Oki Mark K SVP, CFO and Sec | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (73%) 13.79K to 3.79K | 77% |
| 29-Aug-12 5:35 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 14-Aug-12 | Gift | 1,116 | -- | -- | 4% 29.59K to 30.71K | |
| 29-Aug-12 5:35 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 14-Aug-12 | Gift | 1,116 | -- | -- | (4%) 30.71K to 29.59K | |
| 08-Jun-12 4:57 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 65,516 | $0.34 | $22,151.00 | (14%) 461.5K to 395.99K | 72% |
| 08-Jun-12 4:56 PM View: | Cassella James V SVP, Research & Development | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 46,222 | $0.34 | $15,627.70 | (23%) 204.02K to 157.8K | 72% |
| 08-Jun-12 4:46 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 46,222 | $0.34 | $15,627.70 | (20%) 225.82K to 179.6K | 72% |
| 08-Jun-12 4:51 PM View: | Oki Mark K VP Fin Controller PAO PFO Sec | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 31,873 | $0.34 | $10,776.30 | (19%) 169.77K to 137.9K | 72% |
| 14-May-12 4:51 PM View: | Oki Mark K VP Fin Controller PAO PFO Sec | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 143% 69.77K to 169.77K | |
| 14-May-12 4:42 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 79% 125.83K to 225.82K | |
| 14-May-12 4:38 PM View: | Cassella James V SVP, Research & Development | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 96% 104.02K to 204.02K | |
| 14-May-12 4:57 PM View: | King Thomas Braxton Pres & CEO Director | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 28% 361.5K to 461.5K | |
| 11-Apr-12 6:03 PM View: | Ringold Gordon Director | Alexza Pharmaceuticals Inc. (ALXA) | 09-Apr-12 | Market Purchase | 100,000 | $0.54 | $54,000.00 | 70% 142.48K to 242.48K | (81%) |
| 26-Mar-12 5:50 PM View: | Oki Mark K VP Fin Controller PAO PFO Sec | Alexza Pharmaceuticals Inc. (ALXA) | 23-Mar-12 | Grant | 31,873 | -- | -- | 84% 37.9K to 69.77K | |
| 26-Mar-12 5:52 PM View: | Simms Michael J SVP, Operations & Manuf | Alexza Pharmaceuticals Inc. (ALXA) | 23-Mar-12 | Grant | 46,222 | -- | -- | 58% 79.6K to 125.83K | |
| 26-Mar-12 5:47 PM View: | Cassella James V SVP, Research & Development | Alexza Pharmaceuticals Inc. (ALXA) | 23-Mar-12 | Grant | 46,222 | -- | -- | 80% 57.8K to 104.02K |
